Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Baxter International
(NY:
BAX
)
34.02
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Baxter International
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Peering Into Baxter Intl's Recent Short Interest
March 27, 2025
Via
Benzinga
Baxter to Host Annual Meeting of Stockholders in Virtual Format
March 26, 2025
From
Baxter International Inc.
Via
Business Wire
What's going on in today's after hours session: S&P500 movers
March 17, 2025
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment.
Via
Chartmill
Baxter (BAX): Buy, Sell, or Hold Post Q4 Earnings?
March 11, 2025
Over the past six months, Baxter’s stock price fell to $36.42. Shareholders have lost 7.3% of their capital, which is disappointing considering the S&P 500 has climbed by 1.5%. This might have...
Via
StockStory
Topics
Stocks
Exposures
US Equities
Demystifying Baxter Intl: Insights From 4 Analyst Reviews
February 26, 2025
Via
Benzinga
Earnings Scheduled For February 20, 2025
February 20, 2025
Via
Benzinga
Earnings Scheduled For February 13, 2025
February 13, 2025
Via
Benzinga
DraftKings To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Monday
March 10, 2025
Via
Benzinga
What To Expect From CooperCompanies’s (COO) Q4 Earnings
March 05, 2025
Medical device company CooperCompanies (NASDAQ:COO) will be reporting results tomorrow after market close. Here’s what you need to know.
Via
StockStory
Baxter Unveils Voalte Linq Device Powered by Scotty Assistant at HIMSS25 to Advance Voice-Activated Technology in Hospital Settings
March 04, 2025
From
Baxter International Inc.
Via
Business Wire
Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest
February 28, 2025
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at medical devices & supplies - diversified...
Via
StockStory
“From Left For Dead To Loved Again” Stock Market (and Sentiment Results)…
February 27, 2025
Healthcare is the top-performing sector in the market, up 7.31% and outperforming the S&P 500 by 4.2x. Looks like the rumors of its death were indeed GREATLY EXAGGERATED.
Via
Talk Markets
Topics
Stocks
Stocks / Equities
Exposures
US Equities
Baxter to Present at Barclays 27th Annual Global Healthcare Conference
February 25, 2025
From
Baxter International Inc.
Via
Business Wire
Q4 Earnings Roundup: Baxter (NYSE:BAX) And The Rest Of The Medical Devices & Supplies - Diversified Segment
February 25, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices & supplies - diversified stocks fared in Q4,...
Via
StockStory
Exploring the top movers within the S&P500 index during today's session.
February 24, 2025
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
Via
Chartmill
Q4 Earnings Highs And Lows: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
February 24, 2025
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Neogen (NASDAQ:NEOG) and its peers.
Via
StockStory
Uncover the latest developments among S&P500 stocks in today's session.
February 20, 2025
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Thursday. Uncover the top gainers and losers in today's session for valuable insights.
Via
Chartmill
What's going on in today's session: S&P500 movers
February 20, 2025
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
Via
Chartmill
Baxter Q4 Earnings Beat Expectations, Issues Strong 2025 Outlook
February 20, 2025
Baxter International exceeded Q4 earnings and revenue estimates, with strong pharmaceutical sales. The company issued a mixed 2025 outlook amid cost pressures.
Via
Benzinga
Topics
Earnings
Exposures
Financial
Which S&P500 stocks are moving before the opening bell on Thursday?
February 20, 2025
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.
Via
Chartmill
Baxter (NYSE:BAX) Beats Q4 Sales Targets, Stock Soars
February 20, 2025
Healthcare company Baxter International (NYSE:BAX) beat Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $2.75 billion. On the other hand, next quarter’s revenue...
Via
StockStory
Baxter Reports Fourth-Quarter and Full-Year 2024 Results
February 20, 2025
From
Baxter International Inc.
Via
Business Wire
Baxter Earnings: What To Look For From BAX
February 19, 2025
Healthcare company Baxter International (NYSE:BAX) will be reporting earnings tomorrow morning. Here’s what investors should know.
Via
StockStory
Baxter to Present at TD Cowen 45th Annual Health Care Conference
February 18, 2025
From
Baxter International Inc.
Via
Business Wire
Baxter to Present at Raymond James & Associates’ 46th Annual Institutional Investors Conference
February 17, 2025
From
Baxter International Inc.
Via
Business Wire
Baxter to Present at Citi - 2025 Medtech & Life Sciences Access Day
February 13, 2025
From
Baxter International Inc.
Via
Business Wire
What To Expect From Baxter’s (BAX) Q4 Earnings
February 12, 2025
Healthcare company Baxter International (NYSE:BAX) will be announcing earnings results tomorrow morning. Here’s what investors should know.
Via
StockStory
Baxter Declares Quarterly Dividend
February 11, 2025
From
Baxter International Inc.
Via
Business Wire
Deal Dispatch: PharmChem Forgoes Banker To Run Sale, TGI Fridays Sells 19 Restaurants For $3.1 Million
February 07, 2025
Bausch + Lomb's efforts to sell have so far been unsuccessful. Meanwhile, KKR is aggressively pursuing a deal for Fuji Soft.
Via
Benzinga
Baxter Announces CEO Retirement and Appointment of COO
February 03, 2025
From
Baxter International Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.